Medincell: UZEDY®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook
Go back to Medincell: UZEDY®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 40.51 +1.53 (3.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.98 | 52 Week High | $66.55 | |||
| Open | $39.09 | 52 Week Low | $37.82 | |||
| Day High | $40.79 | P/E | N/A | |||
| Day Low | $38.36 | EPS | $0.00 | |||
| Volume | 3,533,640 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 40.51 +1.53 (3.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.98 | 52 Week High | $66.55 | |||
| Open | $39.09 | 52 Week Low | $37.82 | |||
| Day High | $40.79 | P/E | N/A | |||
| Day Low | $38.36 | EPS | $0.00 | |||
| Volume | 3,533,640 | |||||

